Skip to content

Glenmark Pharma launches combination drug for diabetic patients

This fixed-dose combination offers patients with Type 2 diabetes the convenience of once daily dosing to improve their glycemic control. It is priced at Rs 14.90 per day, thereby reducing the daily cost of therapy by 40 per cent, making it more affordable to the masses, the company said in a statement.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish